Bringing Relief for Chronic Hyperuricemia and Gout Management

ASITANILA Remedies presents XEBULAST 40 mg Tablets, a crucial medication for the chronic management of hyperuricemia (elevated blood uric acid levels) in adult patients with gout.

Key Indication

XEBULAST 40 mg is indicated for the chronic management of hyperuricemia in adult patients with gout.

Gout is a type of inflammatory arthritis caused by the deposition of uric acid crystals in the joints, leading to sudden, painful episodes (gout flares). By reducing uric acid levels, XEBULAST helps prevent the formation of these crystals.

Mechanism of Action

XEBULAST contains Febuxostat, a non-purine selective inhibitor of the enzyme Xanthine Oxidase (XO).

1. Uric Acid Production: The enzyme Xanthine Oxidase is responsible for converting purines into uric acid in the body.

2. Inhibition: Febuxostat blocks the action of this enzyme, thereby reducing the production of uric acid.

3. Result: This leads to lower serum uric acid levels, which is the primary therapeutic goal for gout management, helping to dissolve existing uric acid crystals and prevent future gout attacks.

Dosage and Administration

The recommended starting dose of XEBULAST (Febuxostat) is 40 mg once daily.

· It can be taken with or without food.

· The dosage may be adjusted by a healthcare professional based on the patient\\\'s serum uric acid levels.

· It is crucial to take this medication exactly as prescribed by your doctor.

· Prophylaxis against gout flares (using NSAIDs or Colchicine) is generally recommended when initiating therapy to prevent acute attacks that may occur during the initial phase of uric acid lowering.

Important Safety Information (For Healthcare Professionals & Patients)

Cautionary Note: Patients should be advised to consult their healthcare provider for a complete assessment of the risks and benefits associated with Febuxostat, particularly those with a history of cardiovascular disease.